Zachary Klaassen speaks with Jie Luo about his Prostate Cancer Foundation Young Investigator Award work on androgen receptor enhanceosomes in prostate cancer. Dr. Luo explains that enhanceosomes are ...
ESMO 2024, Prostate Cancer, transdermal estradiol, LHRH agonists, Transdermal Estradiol Versus LHRH Agonists, Androgen Suppression in M0 Prostate Cancer, STAMPEDE trial.
Andrew Hahn discusses the LenCabo study, a randomized phase 2 trial comparing lenvatinib plus everolimus versus cabozantinib for metastatic clear cell renal cell carcinoma progressing on PD-1 ...
In this discussion, Matthew Cooperberg, MD, speaks with Monique Roobol, PhD, lead author of the NEJM publication “European Study of Prostate Cancer Screening - 23-Year Follow-up.” Dr. Roobol reviews ...
Oliver Sartor: Hi, I'm Oliver Sartor with Uro Today, covering metastatic castration resistant prostate cancer at ASCO 2025. A real delight for me to welcome Mark Stein, associate professor at Columbia ...
ESMO 2025 Androgen Receptor Inhibitors (ARIs) versus Abiraterone, Metastatic Hormone-Sensitive Prostate Cancer (mHSPC), apalutamide and enzalutamide.
ESMO 2025 Albumin Binding PSMA Ligand [¹⁷⁷Lu]Ludotadipep, metastatic castration-resistant prostate cancer (mCRPC), NCT05579184.
Patient Out-of-Pocket Costs for Guideline-Recommended Treatments for Erectile Dysfunction: A Medicare Cost Modeling Analysis - Beyond the Abstract ...
UroToday - GU OncToday brings coverage of the clinically relevant content needed to stay at the forefront of the dynamic field of GU oncology and urology.
Certain foods, liquids and beverages, medications and even herbs can “trigger” your bladder symptoms. Their effect on the bladder is not always understood and the same food or liquid may affect ...
UroToday - GU OncToday brings coverage of the clinically relevant content needed to stay at the forefront of the dynamic field of GU oncology and urology.
AUA 2025 trial protocol of CORE-008, intravesical cretostimogene grenadenorepvec, non-muscle invasive bladder cancer (NMIBC), RB-E2F alterations.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈